News

EMD Serono Media Center

Immerse yourself in the fascinating world of a healthcare company. Explore the latest news from the media center and stay up-to-date.

Latest News

View all news

Press Releases

Two-Year Data of Pimicotinib Demonstrated Durable Tumor Control and Sustained ...

Among patients initially randomized to pimicotinib, improvements in symptoms and joint function were observed as early as Week 5, sustained through two years, and continued to improve over time.

2026/10/26
Press Releases

EMD Serono to Present 25 Abstracts at ESMO 2026 Highlighting Advances Across ...

Abstracts highlight established medicines and investigational candidates across multiple tumor types, including TGCT, CRC, UC, NSCLC, SCCHN, desmoid- and other solid-tumors

2026/10/19
Press Releases

EMD Serono Announces FDA Breakthrough Therapy Designation for Enpatoran in ...

FDA's decision was supported by Phase 2 WILLOW study results, which demonstrated meaningful symptoms improvement, particularly among patients with active cutaneous manifestations.

2026/07/08

Media Center

The Media Center is a service for journalists, bloggers and online multipliers that allows you to access news about EMD Serono.

Get in Touch

Contact the EMD Serono US Communications Team via email.

Email Us
Media Downloads

Browse and download high-quality images and video footage.
Access gallery
Press Releases

Browse our news releases or filter by topic, year, and month.

Press Releases

YOU MIGHT ALSO BE INTERESTED IN